Novavax boosted on RSV trial results; Medicines Co. says PhIII Oritavancin study a success; Ultragenyx cites positive PhII results for rare disease drug;

 @FierceBiotech: Researchers spotlight two cases of eradicated HIV infection. Story | Follow @FierceBiotech

 @JohnCFierce: FDA cuts the regulatory fuse on Roche's heir to Rituxan. More | Follow @JohnCFierce

 @RyanMFierce: GlaxoSmithKline, J&J make early progress with monthly HIV combo. News | Follow @RyanMFierce

 @EmilyMFierce: Texas A&M launches multimillion-dollar genomics research project. Item | Follow @EmilyMFierce

> Novavax ($NVAX) shares were boosted slightly by upbeat data from an early-stage trial of its RSV vaccine. Report

> Ultragenyx, a startup focused on rare diseases, says it has nabbed positive interim results from a Phase II study of UX001 in 47 patients with hereditary inclusion body myopathy, a progressive muscle-wasting disease. Release

> Jason Rhodes has been promoted to president of Epizyme, which recently pulled off a hot IPO. Rhodes will continue as CFO, reporting to CEO Robert Gould. Release

> Biogen Idec ($BIIB) and Swedish Orphan Biovitrum AB presented new findings for their long-lasting recombinant factor IX candidate Alprolix for hemophilia B. Release

Medical Device News

 @FierceMedDev: Device tax opponents may have gained their opening. Item | Follow @FierceMedDev

 @MarkHFierce: Give us your FMD Fierce 15 nominations today. And spread the word.... More | Follow @MarkHFierce

 @DamianFierce: GI Dynamics has raised $52.2M to get its anti-obesity device through the FDA process. Story | Follow @DamianFierce

> Philips brings updated interventional X-ray system to U.S. market. News

> Clock ticking on vaginal mesh lawsuits against J&J, others. Story

> Study links sales reps at hospitals to higher healthcare costs. More 

Pharma News

 @FiercePharma: Chile's CFR Pharma offers $1.3B for leading South African drug maker Adcock Ingram. Will Bidvest come back? Article | Follow @FiercePharma

 @CarlyHFierce: ICYMI: King Pharmaceuticals settles for $2.2M after violating pharma emissions standards. More | Follow @CarlyHFierce

> Drugmakers to open their doc-payment books in Europe. News

> Under new scrutiny, foreign firms 'have to be careful' in China, experts say. More

> Study confirms pharma's austerity pain in Europe. Story

Drug Delivery News

 @MichaelGFierce:  Mass-produced nanoparticles for drug delivery show market potential. More | Follow @MichaelGFierce

> Avanir drops $110M on novel inhaled-delivery migraine device. News

> UVA researchers find enzyme target for glioblastoma, cancer treatment. Story

> High-dose schizophrenia treatment crosses blood-brain barrier. Read

> Alnylam reports two more positive trials in RNAi arena. More 

And Finally… Investigators at Lund University say that even a modest amount of exercise will spur positive epigenetic changes in fat cells that change the way the body stores fat. Release